(Q28182735)

https://api.crossref.org/works/10.1016/S1388-9842(03)00163-6

30 March 2024

0 references

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/S1388-9842(03)00163-6

30 March 2024

5

Karl Swedberg

0 references

Jean Rouleau

3

object named as

Jean Rouleau

0 references

Jay N. Cohn

1

object named as

Jay N Cohn

0 references

author name string

Norman Sharpe

4

0 references

Matthias Straub

6

0 references

Curtis Wiltse

7

0 references

Marc A. Pfeffer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607206

30 March 2024

Theressa J. Wright

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607206

30 March 2024

MOXCON Investigators

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607206

full work available at URL

30 March 2024

language of work or name

English

0 references

publication date

October 2003

0 references

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/S1388-9842%2803%2900163-6

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607206

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2FS1388-9842(03)00163-6

30 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1388-9842(03)00163-6

https://onlinelibrary.wiley.com/doi/pdf/10.1016/S1388-9842%2803%2900163-6

30 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1388-9842(03)00163-6

European Journal of Heart Failure

30 March 2024

published in

0 references

volume

5

0 references

issue

5

0 references

page(s)

659-67

0 references

cites work

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

Adverse consequences of high sympathetic nervous activity in the failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

Relationship between plasma norepinephrine and sympathetic neural activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

Suppressing sympathetic activation in congestive heart failure. A new therapeutic strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

7 January 2021

Adrenergic effects on the biology of the adult mammalian cardiocyte

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

7 January 2021

Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

7 January 2021

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

7 January 2021

Acute and short-term effects of clonidine in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

7 January 2021

The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure. Moxonidine Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

7 January 2021

The effects of chronic, sustained-release moxonidine therapy on clinical and neurohumoral status in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

7 January 2021

beta-blockers, angiotensin II, and ACE inhibitors in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900163-6

7 January 2021

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017